Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowSeptember 30, 2025 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Crinetics Pharmaceuticals (Nasdaq: CRNX), a pharmaceutical company focused on the discovery, development, and commercialization of the next generation of therapeutics for patients with endocrine and endocrine-rooted diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Scott Struthers, Founder and Chief Executive Officer, rings the Opening Bell.
